| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
52,545 |
39,170 |
$3.01M |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
50,933 |
38,874 |
$821K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
38,067 |
28,463 |
$536K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
7,752 |
6,077 |
$170K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
608 |
496 |
$58.96 |